openPR Logo
Press release

Monoclonal Antibody Therapy Market 2018 |New Business Opportunities and Investment | Most Eminent Players- AbbVie Inc., Amgen Inc., Bayer AG, Biogen Inc., Bristol–Myers Squibb Company

10-08-2018 07:48 AM CET | Health & Medicine

Press release from: Market Research Future

Monoclonal Antibody Therapy Market 2018 |New Business

Market Report Titled "Monoclonal Antibody Therapy Market Research Report – Forecast to 2023" is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally .

Global Monoclonal Antibody Therapy Market –Highlights

The global monoclonal antibody therapy market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future.

Try Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/2089

Antibodies are an important part of the immune system.  Generally, our body creates antibodies in response to an antigen entering the body. 

These antibodies attach to the antigen in order to mark it as harmful which is then destroyed by the body's immune system. Monoclonal Antibodies are the antibodies produced in the laboratory which can mimic the function of a normal antibody to attack the antigen.

However, monoclonal antibodies are engineered in such a way that they identify and attach to the mono-specific targeted antigen on the surface of the cancer cell or any other foreign cell. It is often referred to as a targeted immunotherapy.

Monoclonal antibodies identify and destroy the tumor cells without causing any harm to the normal healthy cells of the body.

The major application of the monoclonal antibody therapy is the treatment of the cancer. Having said that, Monoclonal antibody therapy can only be done for the cancers in which the antigens have been identified so far.

Some of the common monoclonal antibodies are Alemtuzumab, Rituximab, Trastuzumab, Gemtuzumab ozogamicin, Ibritumomab Tioxetan.

For Detailed Reading Visit @ https://www.marketresearchfuture.com/reports/monoclonal-antibody-therapy-market-2089

Global Monoclonal Antibody Therapy Market –Leading Players

AbbVie Inc.
Amgen Inc.
Bayer AG
Biogen Inc.
Bristol–Myers Squibb Company
F. Hoffmann-La Roche Ltd.
GenScript
GlaxoSmithKline Plc.
Johnson & Johnson
Merck KGaA

Global Monoclonal Antibody Therapy Market –Regional Analysis

Depending on geographic region, monoclonal antibody therapy market is segmented into four key regions:  America, Europe, Asia-Pacific, and Middle East & Africa. Globally, America is the largest market for monoclonal antibody therapy.

North American region is the leading market in the America region. Europe is the second-largest market globally for monoclonal antibody therapy which is expected to continue its growth in the near future. Asia pacific region is expected to be fastest growing region in monoclonal antibody therapy market.

Global Monoclonal Antibody Therapy Market –Segmentation

Monoclonal antibody therapy market has been segmented on the basis of source which comprises of recombinant, chimeric, humanized, human, and other. 

On the basis of application, market is segmented into diagnostic test, analytical and chemical uses, cancer treatment, autoimmune diseases, hematological disorders, and others. On the basis of end user, market is segmented into hospitals, clinic, research laboratories and others.

Feel Free to Ask Any Query @ https://www.marketresearchfuture.com/enquiry/2089

Some Points form TOC for Monoclonal Antibody Therapy Market Research Report – Forecast to 2023

1 Introduction

1.1 Definition

1.2 Scope of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monoclonal Antibody Therapy Market 2018 |New Business Opportunities and Investment | Most Eminent Players- AbbVie Inc., Amgen Inc., Bayer AG, Biogen Inc., Bristol–Myers Squibb Company here

News-ID: 1285601 • Views:

More Releases from Market Research Future

US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2024 to 2032
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Futu …
The Construction Internet of Things (IoT) market is rapidly expanding, revolutionizing the construction industry by enhancing productivity, safety, and efficiency. IoT in construction involves the use of sensors, devices, and software to collect and analyze data in real-time, enabling better decision-making and optimization of construction processes. The Construction IoT Market is estimated at US$ 51.78 billion in 2032 and is forecasted to increase rapidly at a CAGR of 16.8% from 2024
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segmentation, Revenue and Industry Expansion Forecast Report
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segm …
The logistics and supply chain market is a critical backbone of global commerce, ensuring the seamless flow of goods from production to consumption. It encompasses a vast network of processes, technologies, and providers working together to deliver products to customers efficiently and cost-effectively. Logistics & Supply Chain Market was valued at USD 9.1 Billion in 2024 and is expected to reach USD 14.72 Billion by 2032, registering a CAGR of 6.20%

All 5 Releases


More Releases for Monoclonal

Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity